var path='https://www.tickertech.net'; function heading(heading) { document.write('
'+heading+' |
'+ ''+ ' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('4/29 - 8:04 AM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory | \n'); } if (allow) { document.write('
4/24 - 4:05 PM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR Stereotactic System | \n'); } if (allow) { document.write('
4/23 - 4:05 PM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024 | \n'); } if (allow) { document.write('
4/16 - 4:05 PM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations | \n'); } if (allow) { document.write('
4/8 - 9:16 AM \; \; | \n'); } if (allow) { document.write('SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ClearPoint Neuro, Inc. (NASDAQ: CLPT) | \n'); } if (allow) { document.write('
3/19 - 8:08 AM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza as a Treatment for AADC Deficiency | \n'); } if (allow) { document.write('
3/12 - 4:05 PM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results | \n'); } if (allow) { document.write('
3/11 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism Neuro Laser Therapy System | \n'); } if (allow) { document.write('
3/1 - 4:05 PM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024 | \n'); } if (allow) { document.write('
2/29 - 8:00 AM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock | \n'); } if (allow) { document.write('
2/28 - 4:46 PM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Launches Proposed Public Offering of Common Stock | \n'); } if (allow) { document.write('
2/21 - 4:05 PM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model | \n'); } if (allow) { document.write('
1/24 - 4:05 PM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo | \n'); } if (allow) { document.write('
1/22 - 4:05 PM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe | \n'); } if (allow) { document.write('
1/16 - 8:03 AM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Announces FDA Clearance for SmartFrame OR Stereotactic System | \n'); } if (allow) { document.write('
1/9 - 12:55 PM \; \; | \n'); } if (allow) { document.write('Tuesday Sector Leaders: Manufacturing, Medical Instruments & Supplies [VIDEO] | \n'); } if (allow) { document.write('
1/8 - 4:05 PM \; \; | \n'); } if (allow) { document.write('ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue | \n'); } if (allow) { document.write('
\n'); } if (allow) { document.write(' |